Familial defective apolipoprotein B-100: Low density lipoproteins with abnormal receptor binding

T. L. Innerarity, K. H. Weisgraber, K. S. Arnold, R. W. Mahley, R. M. Krauss, Gloria L Vega, Scott M Grundy

Research output: Contribution to journalArticle

344 Citations (Scopus)

Abstract

Previous in vivo turnover studies suggested that retarded clearance of low density lipoproteins (LDL) from the plasma of some hypercholesterolemic patients is due to LDL with defective receptor binding. The present study examined this postulate directly by receptor binding experiments. The LDL from a hypercholesterolemic patient (G.R.) displayed a reduced ability to bind to the LDL receptors on normal human fibroblasts. The G.R. LDL possessed 32% of normal receptor binding activity (≃ 9.3 μg of G.R. LDL per ml were required to displace 50% of 125I-labeled normal LDL, vs. ≃ μg of normal LDL per ml). Likewise, the G.R. LDL were much less effective than normal LDL in competing with 125I-labeled normal LDL for cellular uptake and degradation and in stimulating intracellular cholesteryl ester synthesis. The defect in LDL binding appears to be due to a genetic abnormality of apolipoprotein B-100: two brothers of the proband posses LDL defective in receptor binding, whereas a third brother and the proband's son have normally binding LDL. Further, the defect in receptor binding does not appear to be associated with an abnormal lipid composition or structure of the LDL: the chemical and physical properties of the particles were normal, and partial delipidation of the LDL did not alter receptor binding activity. Normal and abnormal LDL subpopulations were partially separated from plasma of two subjects by density-gradient ultracentrifugation, a finding consistent with the presence of a normal and a mutant allele. The affected family members appear to be heterozygous for this disorder, which has been designated familial defective apolipoprotein B-100. These studies indicate that the defective receptor binding results in inefficient clearance of LDL and the hypercholesterolemia observed in these patients.

Original languageEnglish (US)
Pages (from-to)6919-6923
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume84
Issue number19
StatePublished - 1987

Fingerprint

Hyperlipoproteinemia Type II
LDL Lipoproteins
Siblings
Apolipoprotein B-100
Aptitude
Cholesterol Esters
LDL Receptors
Ultracentrifugation

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Familial defective apolipoprotein B-100 : Low density lipoproteins with abnormal receptor binding. / Innerarity, T. L.; Weisgraber, K. H.; Arnold, K. S.; Mahley, R. W.; Krauss, R. M.; Vega, Gloria L; Grundy, Scott M.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 84, No. 19, 1987, p. 6919-6923.

Research output: Contribution to journalArticle

@article{34ae8e16a02d42a48c60f911c04b5eb0,
title = "Familial defective apolipoprotein B-100: Low density lipoproteins with abnormal receptor binding",
abstract = "Previous in vivo turnover studies suggested that retarded clearance of low density lipoproteins (LDL) from the plasma of some hypercholesterolemic patients is due to LDL with defective receptor binding. The present study examined this postulate directly by receptor binding experiments. The LDL from a hypercholesterolemic patient (G.R.) displayed a reduced ability to bind to the LDL receptors on normal human fibroblasts. The G.R. LDL possessed 32{\%} of normal receptor binding activity (≃ 9.3 μg of G.R. LDL per ml were required to displace 50{\%} of 125I-labeled normal LDL, vs. ≃ μg of normal LDL per ml). Likewise, the G.R. LDL were much less effective than normal LDL in competing with 125I-labeled normal LDL for cellular uptake and degradation and in stimulating intracellular cholesteryl ester synthesis. The defect in LDL binding appears to be due to a genetic abnormality of apolipoprotein B-100: two brothers of the proband posses LDL defective in receptor binding, whereas a third brother and the proband's son have normally binding LDL. Further, the defect in receptor binding does not appear to be associated with an abnormal lipid composition or structure of the LDL: the chemical and physical properties of the particles were normal, and partial delipidation of the LDL did not alter receptor binding activity. Normal and abnormal LDL subpopulations were partially separated from plasma of two subjects by density-gradient ultracentrifugation, a finding consistent with the presence of a normal and a mutant allele. The affected family members appear to be heterozygous for this disorder, which has been designated familial defective apolipoprotein B-100. These studies indicate that the defective receptor binding results in inefficient clearance of LDL and the hypercholesterolemia observed in these patients.",
author = "Innerarity, {T. L.} and Weisgraber, {K. H.} and Arnold, {K. S.} and Mahley, {R. W.} and Krauss, {R. M.} and Vega, {Gloria L} and Grundy, {Scott M}",
year = "1987",
language = "English (US)",
volume = "84",
pages = "6919--6923",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - Familial defective apolipoprotein B-100

T2 - Low density lipoproteins with abnormal receptor binding

AU - Innerarity, T. L.

AU - Weisgraber, K. H.

AU - Arnold, K. S.

AU - Mahley, R. W.

AU - Krauss, R. M.

AU - Vega, Gloria L

AU - Grundy, Scott M

PY - 1987

Y1 - 1987

N2 - Previous in vivo turnover studies suggested that retarded clearance of low density lipoproteins (LDL) from the plasma of some hypercholesterolemic patients is due to LDL with defective receptor binding. The present study examined this postulate directly by receptor binding experiments. The LDL from a hypercholesterolemic patient (G.R.) displayed a reduced ability to bind to the LDL receptors on normal human fibroblasts. The G.R. LDL possessed 32% of normal receptor binding activity (≃ 9.3 μg of G.R. LDL per ml were required to displace 50% of 125I-labeled normal LDL, vs. ≃ μg of normal LDL per ml). Likewise, the G.R. LDL were much less effective than normal LDL in competing with 125I-labeled normal LDL for cellular uptake and degradation and in stimulating intracellular cholesteryl ester synthesis. The defect in LDL binding appears to be due to a genetic abnormality of apolipoprotein B-100: two brothers of the proband posses LDL defective in receptor binding, whereas a third brother and the proband's son have normally binding LDL. Further, the defect in receptor binding does not appear to be associated with an abnormal lipid composition or structure of the LDL: the chemical and physical properties of the particles were normal, and partial delipidation of the LDL did not alter receptor binding activity. Normal and abnormal LDL subpopulations were partially separated from plasma of two subjects by density-gradient ultracentrifugation, a finding consistent with the presence of a normal and a mutant allele. The affected family members appear to be heterozygous for this disorder, which has been designated familial defective apolipoprotein B-100. These studies indicate that the defective receptor binding results in inefficient clearance of LDL and the hypercholesterolemia observed in these patients.

AB - Previous in vivo turnover studies suggested that retarded clearance of low density lipoproteins (LDL) from the plasma of some hypercholesterolemic patients is due to LDL with defective receptor binding. The present study examined this postulate directly by receptor binding experiments. The LDL from a hypercholesterolemic patient (G.R.) displayed a reduced ability to bind to the LDL receptors on normal human fibroblasts. The G.R. LDL possessed 32% of normal receptor binding activity (≃ 9.3 μg of G.R. LDL per ml were required to displace 50% of 125I-labeled normal LDL, vs. ≃ μg of normal LDL per ml). Likewise, the G.R. LDL were much less effective than normal LDL in competing with 125I-labeled normal LDL for cellular uptake and degradation and in stimulating intracellular cholesteryl ester synthesis. The defect in LDL binding appears to be due to a genetic abnormality of apolipoprotein B-100: two brothers of the proband posses LDL defective in receptor binding, whereas a third brother and the proband's son have normally binding LDL. Further, the defect in receptor binding does not appear to be associated with an abnormal lipid composition or structure of the LDL: the chemical and physical properties of the particles were normal, and partial delipidation of the LDL did not alter receptor binding activity. Normal and abnormal LDL subpopulations were partially separated from plasma of two subjects by density-gradient ultracentrifugation, a finding consistent with the presence of a normal and a mutant allele. The affected family members appear to be heterozygous for this disorder, which has been designated familial defective apolipoprotein B-100. These studies indicate that the defective receptor binding results in inefficient clearance of LDL and the hypercholesterolemia observed in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0011723065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0011723065&partnerID=8YFLogxK

M3 - Article

C2 - 3477815

AN - SCOPUS:0011723065

VL - 84

SP - 6919

EP - 6923

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -